Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.
Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.
复制标题
DOI:
10.1111/ijcp.12823
复制
发表时间:
2016-07
影响因子:
2.6
通讯作者:
Marfella R
中科院分区:
文献类型:
--
作者:
Sardu C;Santamaria M;Rizzo MR;Barbieri M;di Marino M;Paolisso G;Santulli G;Marfella R
Telemonitoring (TM) is a safe and efficient monitoring system for internal cardioverter defibrillator device (ICD) recipients. TM has been used to track info on the clinical status of heart failure patients treated by ICD and/or cardiac resynchronisation therapy defibrillator (CRT-D). The aim of this study was to investigate the impact of TM on clinical outcomes in a population of CRT-D patients with heart failure. In a multicentre, randomised study, patients with chronic heart failure, New York Heart Association (NYHA) functional class II or III, left bundle branch block, severe left ventricle ejection fraction reduction (LVEF < 35%) have been identified and screened. One hundred and ninety-one patients have been randomised to receive either a CRT-D with TM or a CRT-D with traditional ambulatory monitoring (control group) and completed the 12-month study follow-up. Primary endpoints were all cause death, cardiac death and hospital admission for heart failure. Secondary endpoints were atrial fibrillation, sustained episodes, non-sustained and self terminated ventricular tachyarrhythmia, sustained ventricular tachycardia, and ventricular fibrillation, ICD shocks and percentage of CRT-D responder patients. Univariate analysis identified the following factors predicting hospitalisation: TM, age, chronic kidney disease, hypercholesterolaemia, LVEF and NYHA class. At multivariate analysis, TM was the only factor predicting heart failure hospitalisation (hazard ratio 0.6, 0.42–0.79, 95% CI, p = 0.002), without affecting overall mortality and cardiac deaths events. Taken together, our data indicate the importance of TM in predicting heart failure hospitalisation in patients treated with CRT-D.
登录
查看更多内容
影响因子:
168.9
作者:
Hindricks, Gerhard;Taborsky, Milos;Sogaard, Peter
通讯作者:
Sogaard, Peter
影响因子:
39
作者:
Ong MK;Romano PS;Edgington S;Aronow HU;Auerbach AD;Black JT;De Marco T;Escarce JJ;Evangelista LS;Hanna B;Ganiats TG;Greenberg BH;Greenfield S;Kaplan SH;Kimchi A;Liu H;Lombardo D;Mangione CM;Sadeghi B;Sadeghi B;Sarrafzadeh M;Tong K;Fonarow GC;Better Effectiveness After Transition–Heart Failure (BEAT-HF) Research Group
通讯作者:
Better Effectiveness After Transition–Heart Failure (BEAT-HF) Research Group
DOI:
10.1056/nejmoa1010029
发表时间:
2010-12-09
期刊:
The New England journal of medicine
影响因子:
--
作者:
Chaudhry SI;Mattera JA;Curtis JP;Spertus JA;Herrin J;Lin Z;Phillips CO;Hodshon BV;Cooper LS;Krumholz HM
通讯作者:
Krumholz HM
影响因子:
158.5
作者:
Moss, Arthur J.;Hall, W. Jackson;Zareba, Wojciech
通讯作者:
Zareba, Wojciech
影响因子:
37.8
作者:
Anand, Inder S.;Carson, Peter;Bristow, Michael R.
通讯作者:
Bristow, Michael R.